ATHE Stock Discussion
Alterity Therapeutics Limited Description
Alterity Therapeutics Ltd formerly known as Prana Biotechnology Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing.
Industry: Biotechnology
Keywords: Biotechnology Neuroscience Alzheimer's Disease Gastrointestinal Parkinson's Disease Neurology Toxicology Treatment Of Parkinson's Disease Huntington's Disease Movement Disorders Pathology Anatomical Pathology Brain Cancer Neuropathology Toxicology Testing Treatment Of Alzheimer's
Recent Comments
- Cos3 on Adding float as advanced filter criteria?
- FriendlyOyster657 on BOOT
- TraderMike on Filtering by News?
- Dr_Duru on Filtering by News?
- TraderMike on Filtering by News?
From the Blog
Featured Articles